Inflammatory bowel disease, gut bacteria and probiotic therapy

International Journal of Medical Microbiology

Volumn 300, Issue 1, 2010, Pages 25-33

  Reiff, Caroline ^a   Kelly, Denise ^a  

^a ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Immunomodulation; Inflammatory bowel disease; Intestinal microbiota; Probiotics

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 8; MUCIN; PROBIOTIC AGENT; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; VSL3;

CROHN DISEASE; DENDRITIC CELL; GENETIC SUSCEPTIBILITY; HOMEOSTASIS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; METAGENOMICS; NONHUMAN; REGULATORY T LYMPHOCYTE; SHORT SURVEY; T LYMPHOCYTE ACTIVATION; TIGHT JUNCTION; ULCERATIVE COLITIS;

BACTERIA; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATORY BOWEL DISEASES; PROBIOTICS;

EID: 71949112397     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2009.08.004     Document Type: Short Survey

References (134)

1. Adams R.J., Heazlewood S.P., Gilshenan K.S., O'Brien M., McGuckin M.A., and Florin T.H. IgG antibodies against common gut bacteria are more diagnostic for Crohn's disease than IgG against mannan or flagellin. Am. J. Gastroenterol. 103 (2008) 386-396
2. Ahmed M., Prasad J., Gill H., Stevenson L., and Gopal P. Impact of consumption of different levels of Bifidobacterium lactis HN019 on the intestinal microflora of elderly human subjects. J. Nutr. Health Aging 11 (2007) 26-31
3. Alexa A., Rahnenfuhrer J., and Lengauer T. Improved scoring of functional groups from gene expression data by decorrelating GO graph structure. Bioinformatics 22 (2006) 1600-1607
4. Artis D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat. Rev. Immunol. 8 (2008) 411-420
5. Atarashi K., Nishimura J., Shima T., Umesaki Y., Yamamoto M., Onoue M., Yagita H., Ishii N., Evans R., Honda K., and Takeda K. ATP drives lamina propria T(H)17 cell differentiation. Nature 455 (2008) 808-812
6. Baba N., Samson S., Bourdet-Sicard R., Rubio M., and Sarfati M. Commensal bacteria trigger a full dendritic cell maturation program that promotes the expansion of non-Tr1 suppressor T cells. J. Leukoc. Biol. 84 (2008) 468-476
7. Bai A.P., Ouyang Q., Xiao X.R., and Li S.F. Probiotics modulate inflammatory cytokine secretion from inflamed mucosa in active ulcerative colitis. Int. J. Clin. Pract. 60 (2006) 284-288
8. Bartosch S., Woodmansey E.J., Paterson J.C., McMurdo M.E., and Macfarlane G.T. Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria. Clin. Infect. Dis. 40 (2005) 28-37
9. Bentley R.W., Keenan J.I., Gearry R.B., Kennedy M.A., Barclay M.L., and Roberts R.L. Incidence of Mycobacterium avium subspecies paratuberculosis in a population-based cohort of patients with Crohn's disease and control subjects. Am. J. Gastroenterol. 103 (2008) 1168-1172
10. Caballero-Franco C., Keller K., De S.C., and Chadee K. The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 292 (2007) G315-G322
11. Carey C.M., Kirk J.L., Ojha S., and Kostrzynska M. Current and future uses of real-time polymerase chain reaction and microarrays in the study of intestinal microbiota, and probiotic use and effectiveness. Can. J. Microbiol. 53 (2007) 537-550
12. Cario E. Bacterial interactions with cells of the intestinal mucosa: Toll-like receptors and NOD2. Gut 54 (2005) 1182-1193
13. Cario E., and Podolsky D.K. Intestinal epithelial TOLLerance versus in TOLLerance of commensals. Mol. Immunol. 42 (2005) 887-893
14. Carmody R.J., and Chen Y.H. Nuclear factor-kappaB: activation and regulation during Toll-like receptor signaling. Cell. Mol. Immunol. 4 (2007) 31-41
15. Cash H.L., Whitham C.V., Behrendt C.L., and Hooper L.V. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 313 (2006) 1126-1130
16. Cavalieri D., Castagnini C., Toti S., Maciag K., Kelder T., Gambineri L., Angioli S., and Dolara P. Eu.Gene Analyzer a tool for integrating gene expression data with pathway databases. Bioinformatics 23 (2007) 2631-2632
17. Chermesh I., Tamir A., Reshef R., Chowers Y., Suissa A., Katz D., Gelber M., Halpern Z., Bengmark S., and Eliakim R. Failure of Synbiotic 2000 to prevent postoperative recurrence of Crohn's disease. Dig. Dis. Sci. 52 (2007) 385-389
18. Chow J., and Mazmanian S.K. Getting the bugs out of the immune system: do bacterial microbiota "fix" intestinal T cell responses?. Cell Host Microbe 5 (2009) 8-12
19. Clavel T., and Haller D. Bacteria- and host-derived mechanisms to control intestinal epithelial cell homeostasis: implications for chronic inflammation. Inflamm. Bowel Dis. 13 (2007) 1153-1164
20. D'Haens G.R., Geboes K., Peeters M., Baert F., Penninckx F., and Rutgeerts P. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 114 (1998) 262-267
21. Dalevi D., Ivanova N.N., Mavromatis K., Hooper S.D., Szeto E., Hugenholtz P., Kyrpides N.C., and Markowitz V.M. Annotation of metagenome short reads using proxygenes. Bioinformatics 24 (2008) i7-13
22. Darfeuille-Michaud A., Boudeau J., Bulois P., Neut C., Glasser A.L., Barnich N., Bringer M.A., Swidsinski A., Beaugerie L., and Colombel J.F. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127 (2004) 412-421
23. Di Caro S., Tao H., Grillo A., Elia C., Gasbarrini G., Sepulveda A.R., and Gasbarrini A. Effects of Lactobacillus GG on genes expression pattern in small bowel mucosa. Dig. Liver Dis. 37 (2005) 320-329
24. Di Giacinto C., Marinaro M., Sanchez M., Strober W., and Boirivant M. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J. Immunol. 174 (2005) 3237-3246
25. Dogi C.A., Galdeano C.M., and Perdigon G. Gut immune stimulation by non pathogenic Gram(+) and Gram(-) bacteria. Comparison with a probiotic strain. Cytokine 41 (2008) 223-231
26. Duncan S.H., Louis P., and Flint H.J. Cultivable bacterial diversity from the human colon. Lett. Appl. Microbiol. 44 (2007) 343-350
27. Eaves-Pyles T., Allen C.A., Taormina J., Swidsinski A., Tutt C.B., Jezek G.E., Islas-Islas M., and Torres A.G. Escherichia coli isolated from a Crohn's disease patient adheres, invades, and induces inflammatory responses in polarized intestinal epithelial cells. Int. J. Med. Microbiol. 298 (2008) 397-409
28. Eckburg P.B., Bik E.M., Bernstein C.N., Purdom E., Dethlefsen L., Sargent M., Gill S.R., Nelson K.E., and Relman D.A. Diversity of the human intestinal microbial flora. Science 308 (2005) 1635-1638
29. Ferrante M., Henckaerts L., Joossens M., Pierik M., Joossens S., Dotan N., Norman G.L., Altstock R.T., Van Steen K., Rutgeerts P., Van Assche G., and Vermeire S. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut 56 (2007) 1394-1403
30. Foligne B., Zoumpopoulou G., Dewulf J., Ben Y.A., Chareyre F., Sirard J.C., Pot B., and Grangette C. A key role of dendritic cells in probiotic functionality. PLoS One 2 (2007) e313
31. Frank D.N., St. Amand A.L., Feldman R.A., Boedeker E.C., Harpaz N., and Pace N.R. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. USA 104 (2007) 13780-13785
32. Franke A., Balschun T., Karlsen T.H., Hedderich J., May S., Lu T., Schuldt D., Nikolaus S., Rosenstiel P., Krawczak M., and Schreiber S. Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis. Nat. Genet. 40 (2008) 713-715
33. Franke A., Balschun T., Karlsen T.H., Sventoraityte J., Nikolaus S., Mayr G., Domingues F.S., Albrecht M., Nothnagel M., Ellinghaus D., Sina C., Onnie C.M., Weersma R.K., Stokkers P.C., Wijmenga C., Gazouli M., Strachan D., McArdle W.L., Vermeire S., Rutgeerts P., Rosenstiel P., Krawczak M., Vatn M.H., Mathew C.G., and Schreiber S. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat. Genet. 40 (2008) 1319-1323
34. Fuentes S., Egert M., Jimenez-Valera M., Ramos-Cormenzana A., Ruiz-Bravo A., Smidt H., and Monteoliva-Sanchez M. Administration of Lactobacillus casei and Lactobacillus plantarum affects the diversity of murine intestinal lactobacilli, but not the overall bacterial community structure. Res. Microbiol. 159 (2008) 237-243
35. Furrie E., Macfarlane S., Kennedy A., Cummings J.H., Walsh S.V., O'Neil D.A., and Macfarlane G.T. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut 54 (2005) 242-249
36. Gaboriau-Routhiau, V., Rakotobe, S., Lecuyer, E., Mulder, I., Lan, A., Bridonneau, C., Rochet, V., Pisi, A., De paepe, M., Brandi, G., Eberl, G., Snel, J., Kelly, D., Cerf-Bensussan, N., 2009. The key role of segmented filamentous bacteria in the coordinate maturation of gut helper T cell responses. Immunity, in press
37. Gantner B.N., Simmons R.M., Canavera S.J., Akira S., and Underhill D.M. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J. Exp. Med. 197 (2003) 1107-1117
38. Garcia Vilela E., De Lourdes De Abreu Ferrari M., Oswaldo Da Gama Torres H., Guerra Pinto A., Carolina Carneiro Aguirre A., Paiva Martins F., Marcos Andrade Goulart E., and Sales Da Cunha A. Influence of Saccharomyces boulardii on the intestinal permeability of patients with Crohn's disease in remission. Scand. J. Gastroenterol. 43 (2008) 842-848
39. Gaudier E., Michel C., Segain J.P., Cherbut C., and Hoebler C. The VSL# 3 probiotic mixture modifies microflora but does not heal chronic dextran-sodium sulfate-induced colitis or reinforce the mucus barrier in mice. J. Nutr. 135 (2005) 2753-2761
40. Gill S.R., Pop M., Deboy R.T., Eckburg P.B., Turnbaugh P.J., Samuel B.S., Gordon J.I., Relman D.A., Fraser-Liggett C.M., and Nelson K.E. Metagenomic analysis of the human distal gut microbiome. Science 312 (2006) 1355-1359
41. Gionchetti P., Rizzello F., Venturi A., Brigidi P., Matteuzzi D., Bazzocchi G., Poggioli G., Miglioli M., and Campieri M. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 119 (2000) 305-309
42. Gironella M., Iovanna J.L., Sans M., Gil F., Penalva M., Closa D., Miquel R., Pique J.M., and Panes J. Anti-inflammatory effects of pancreatitis associated protein in inflammatory bowel disease. Gut 54 (2005) 1244-1253
43. Gotz S., Garcia-Gomez J.M., Terol J., Williams T.D., Nagaraj S.H., Nueda M.J., Robles M., Talon M., Dopazo J., and Conesa A. High-throughput functional annotation and data mining with the Blast2GO suite. Nucleic Acids Res. 36 (2008) 3420-3435
44. Gueimonde M., Sakata S., Kalliomaki M., Isolauri E., Benno Y., and Salminen S. Effect of maternal consumption of Lactobacillus GG on transfer and establishment of fecal bifidobacterial microbiota in neonates. J. Pediatr. Gastroenterol. Nutr. 42 (2006) 166-170
45. Guslandi M., Mezzi G., Sorghi M., and Testoni P.A. Saccharomyces boulardii in maintenance treatment of Crohn's disease. Dig. Dis. Sci. 45 (2000) 1462-1464
46. Harada T., Kawaminami H., Miura N.N., Adachi Y., Nakajima M., Yadomae T., and Ohno N. Mechanism of enhanced hematopoietic response by soluble beta-glucan SCG in cyclophosphamide-treated mice. Microbiol. Immunol. 50 (2006) 687-700
47. Hart A.L., Lammers K., Brigidi P., Vitali B., Rizzello F., Gionchetti P., Campieri M., Kamm M.A., Knight S.C., and Stagg A.J. Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 53 (2004) 1602-1609
48. Himmel M.E., Hardenberg G., Piccirillo C.A., Steiner T.S., and Levings M.K. The role of T-regulatory cells and Toll-like receptors in the pathogenesis of human inflammatory bowel disease. Immunology 125 (2008) 145-153
49. Hoarau C., Martin L., Faugaret D., Baron C., Dauba A., Aubert-Jacquin C., Velge-Roussel F., and Lebranchu Y. Supernatant from Bifidobacterium differentially modulates transduction signaling pathways for biological functions of human dendritic cells. PLoS One 3 (2008) e2753
50. Hormannsperger, G.,Clavel, T.,Hoffmann, M., Reiff, C., Kelly, D., Loh, G., Blaut, M., Holzlwimmer, G., Laschinger, M., Haller, D., 2009. Post-translational inhibition of IP-10 in IEC by probiotic bacteria: impact on chronic inflammation. PLoS One 4, e4365
51. Ivanov I.I., Frutos R.L., Manel N., Yoshinaga K., Rifkin D.B., Sartor R.B., Finlay B.B., and Littman D.R. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4 (2008) 337-349
52. Johnson-Henry K.C., Donato K.A., Shen-Tu G., Gordanpour M., and Sherman P.M. Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function. Infect. Immun. 76 (2008) 1340-1348
53. Kappelman M.D., Rifas-Shiman S.L., Kleinman K., Ollendorf D., Bousvaros A., Grand R.J., and Finkelstein J.A. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin. Gastroenterol. Hepatol. 5 (2007) 1424-1429
54. Kelly D., Campbell J.I., King T.P., Grant G., Jansson E.A., Coutts A.G., Pettersson S., and Conway S. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat. Immunol. 5 (2004) 104-112
55. Kelly D., Conway S., and Aminov R. Commensal gut bacteria: mechanisms of immune modulation. Trends Immunol. 26 (2005) 326-333
56. Kim J.B., Porreca G.J., Song L., Greenway S.C., Gorham J.M., Church G.M., Seidman C.E., and Seidman J.G. Polony multiplex analysis of gene expression (PMAGE) in mouse hypertrophic cardiomyopathy. Science 316 (2007) 1481-1484
57. Kim Y., Kim S.H., Whang K.Y., Kim Y.J., and Oh S. Inhibition of Escherichia coli O157:H7 attachment by interactions between lactic acid bacteria and intestinal epithelial cells. J. Microbiol. Biotechnol. 18 (2008) 1278-1285
58. Kobayashi T., Okamoto S., Hisamatsu T., Kamada N., Chinen H., Saito R., Kitazume M.T., Nakazawa A., Sugita A., Koganei K., Isobe K., and Hibi T. IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease. Gut 57 (2008) 1682-1689
59. Kotlowski R., Bernstein C.N., Sepehri S., and Krause D.O. High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease. Gut 56 (2007) 669-675
60. Kruis W., Fric P., Pokrotnieks J., Lukas M., Fixa B., Kascak M., Kamm M.A., Weismueller J., Beglinger C., Stolte M., Wolff C., and Schulze J. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53 (2004) 1617-1623
61. Kuhbacher T., Ott S.J., Helwig U., Mimura T., Rizzello F., Kleessen B., Gionchetti P., Blaut M., Campieri M., Folsch U.R., Kamm M.A., and Schreiber S. Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. Gut 55 (2006) 833-841
62. Kumar A., Wu H., Collier-Hyams L.S., Hansen J.M., Li T., Yamoah K., Pan Z.Q., Jones D.P., and Neish A.S. Commensal bacteria modulate cullin-dependent signaling via generation of reactive oxygen species. EMBO J. 26 (2007) 4457-4466
63. Kurokawa K., Itoh T., Kuwahara T., Oshima K., Toh H., Toyoda A., Takami H., Morita H., Sharma V.K., Srivastava T.P., Taylor T.D., Noguchi H., Mori H., Ogura Y., Ehrlich D.S., Itoh K., Takagi T., Sakaki Y., Hayashi T., and Hattori M. Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Res. 14 (2007) 169-181
64. Lam E.K., Tai E.K., Koo M.W., Wong H.P., Wu W.K., Yu L., So W.H., Woo P.C., and Cho C.H. Enhancement of gastric mucosal integrity by Lactobacillus rhamnosus GG. Life Sci. 80 (2007) 2128-2136
65. Ley R.E., Peterson D.A., and Gordon J.I. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124 (2006) 837-848
66. Lin P.W., Nasr T.R., Berardinelli A.J., Kumar A., and Neish A.S. The probiotic Lactobacillus GG may augment intestinal host defense by regulating apoptosis and promoting cytoprotective responses in the developing murine gut. Pediatr. Res. 64 (2008) 511-516
67. Lindfors K., Blomqvist T., Juuti-Uusitalo K., Stenman S., Venalainen J., Maki M., and Kaukinen K. Live probiotic Bifidobacterium lactis bacteria inhibit the toxic effects induced by wheat gliadin in epithelial cell culture. Clin. Exp. Immunol. 152 (2008) 552-558
68. Liu J.R., Yu B., Liu F.H., Cheng K.J., and Zhao X. Expression of rumen microbial fibrolytic enzyme genes in probiotic Lactobacillus reuteri. Appl. Environ. Microbiol. 71 (2005) 6769-6775
69. Lodes M.J., Cong Y., Elson C.O., Mohamath R., Landers C.J., Targan S.R., Fort M., and Hershberg R.M. Bacterial flagellin is a dominant antigen in Crohn disease. J. Clin. Invest. 113 (2004) 1296-1306
70. Loftus Jr. E.V. The burden of inflammatory bowel disease in the United States: a moving target?. Clin. Gastroenterol. Hepatol. 5 (2007) 1383-1384
71. Lutgendorff F., Akkermans L.M., and Soderholm J.D. The role of microbiota and probiotics in stress-induced gastro-intestinal damage. Curr. Mol. Med. 8 (2008) 282-298
72. Magalhaes J.G., Tattoli I., and Girardin S.E. The intestinal epithelial barrier: how to distinguish between the microbial flora and pathogens. Semin. Immunol. 19 (2007) 106-115
73. Mallon, P., McKay, D., Kirk, S., Gardiner, K., 2007. Probiotics for induction of remission in ulcerative colitis. Cochrane Database Syst. Rev. CD005573.
74. Marguerat S., Wilhelm B.T., and Bahler J. Next-generation sequencing: applications beyond genomes. Biochem. Soc. Trans. 36 (2008) 1091-1096
75. Marteau P., Lemann M., Seksik P., Laharie D., Colombel J.F., Bouhnik Y., Cadiot G., Soule J.C., Bourreille A., Metman E., Lerebours E., Carbonnel F., Dupas J.L., Veyrac M., Coffin B., Moreau J., Abitbol V., Blum-Sperisen S., and Mary J.Y. Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial. Gut 55 (2006) 842-847
76. Mazmanian S.K., Round J.L., and Kasper D.L. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453 (2008) 620-625
77. McKenzie H., Main J., Pennington C.R., and Parratt D. Antibody to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease. Gut 31 (1990) 536-538
78. Miettinen M., Veckman V., Latvala S., Sareneva T., Matikainen S., and Julkunen I. Live Lactobacillus rhamnosus and Streptococcus pyogenes differentially regulate Toll-like receptor (TLR) gene expression in human primary macrophages. J. Leukoc. Biol. 84 (2008) 1092-1100
79. Mihajlovski A., Alric M., and Brugere J.F. A putative new order of methanogenic Archaea inhabiting the human gut, as revealed by molecular analyses of the mcrA gene. Res. Microbiol. 159 (2008) 516-521
80. Mimura T., Rizzello F., Helwig U., Poggioli G., Schreiber S., Talbot I.C., Nicholls R.J., Gionchetti P., Campieri M., and Kamm M.A. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 53 (2004) 108-114
81. Mpofu C.M., Campbell B.J., Subramanian S., Marshall-Clarke S., Hart C.A., Cross A., Roberts C.L., McGoldrick A., Edwards S.W., and Rhodes J.M. Microbial mannan inhibits bacterial killing by macrophages: a possible pathogenic mechanism for Crohn's disease. Gastroenterology 133 (2007) 1487-1498
82. Muller S., Arni S., Varga L., Balsiger B., Hersberger M., Maly F., and Seibold F. Serological and DNA-based evaluation of Chlamydia pneumoniae infection in inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 18 (2006) 889-894
83. Niess J.H., Brand S., Gu X., Landsman L., Jung S., McCormick B.A., Vyas J.M., Boes M., Ploegh H.L., Fox J.G., Littman D.R., and Reinecker H.C. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307 (2005) 254-258
84. Niess J.H., Leithauser F., Adler G., and Reimann J. Commensal gut flora drives the expansion of proinflammatory CD4 T cells in the colonic lamina propria under normal and inflammatory conditions. J. Immunol. 180 (2008) 559-568
85. O'Mahony C., Scully P., O'Mahony D., Murphy S., O'Brien F., Lyons A., Sherlock G., MacSharry J., Kiely B., Shanahan F., and O'Mahony L. Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-kappaB activation. PLoS Pathog. 4 (2008) e1000112
86. Ott S.J., Kuhbacher T., Musfeldt M., Rosenstiel P., Hellmig S., Rehman A., Drews O., Weichert W., Timmis K.N., and Schreiber S. Fungi and inflammatory bowel diseases: Alterations of composition and diversity. Scand. J. Gastroenterol. 43 (2008) 831-841
87. Otte J.M., Cario E., and Podolsky D.K. Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology 126 (2004) 1054-1070
88. Palm N.W., and Medzhitov R. Immunostimulatory activity of haptenated proteins. Proc. Natl. Acad. Sci. USA 106 (2009) 4782-4787
89. Papadakis K.A., Yang H., Ippoliti A., Mei L., Elson C.O., Hershberg R.M., Vasiliauskas E.A., Fleshner P.R., Abreu M.T., Taylor K., Landers C.J., Rotter J.I., and Targan S.R. Anti-flagellin (CBir1) phenotypic and genetic Crohn's disease associations. Inflamm. Bowel Dis. 13 (2007) 524-530
90. Papp M., Altorjay I., Dotan N., Palatka K., Foldi I., Tumpek J., Sipka S., Udvardy M., Dinya T., Lakatos L., Kovacs A., Molnar T., Tulassay Z., Miheller P., Norman G.L., Szamosi T., Papp J., and Lakatos P.L. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort. Am. J. Gastroenterol. 103 (2008) 665-681
91. Pene J., Chevalier S., Preisser L., Venereau E., Guilleux M.H., Ghannam S., Moles J.P., Danger Y., Ravon E., Lesaux S., Yssel H., and Gascan H. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J. Immunol. 180 (2008) 7423-7430
92. Prantera C., Scribano M.L., Falasco G., Andreoli A., and Luzi C. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG. Gut 51 (2002) 405-409
93. Pronio A., Montesani C., Butteroni C., Vecchione S., Mumolo G., Vestri A., Vitolo D., and Boirivant M. Probiotic administration in patients with ileal pouch-anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells. Inflamm. Bowel Dis. 14 (2008) 662-668
94. Pulendran B., Tang H., and Denning T.L. Division of labor, plasticity, and crosstalk between dendritic cell subsets. Curr. Opin. Immunol. 20 (2008) 61-67
95. Reiff, C., Delday, M., Rucklidge G., Reid, M., Duncan, G., Wohlgemuth, S., Hormannsperger, G., Loh, G., Blaut, M., Collie-Duguid, E., Haller, D., Kelly, D., 2009. Balancing inflammatory, lipid and exenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowel disease. Inflamm. Bowel Dis., in press.
96. Rescigno M., Urbano M., Valzasina B., Francolini M., Rotta G., Bonasio R., Granucci F., Kraehenbuhl J.P., and Ricciardi-Castagnoli P. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2 (2001) 361-367
97. Rhodes J.M. The role of Escherichia coli in inflammatory bowel disease. Gut 56 (2007) 610-612
98. Rimoldi M., Chieppa M., Salucci V., Avogadri F., Sonzogni A., Sampietro G.M., Nespoli A., Viale G., Allavena P., and Rescigno M. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat. Immunol. 6 (2005) 507-514
99. Rodriguez-Bores L., Fonseca G.C., Villeda M.A., and Yamamoto-Furusho J.K. Novel genetic markers in inflammatory bowel disease. World J. Gastroenterol. 13 (2007) 5560-5570
100. Romualdi A., Felder M., Rose D., Gausmann U., Schilhabel M., Glockner G., Platzer M., and Suhnel J. GenColors: annotation and comparative genomics of prokaryotes made easy. Methods Mol. Biol. 395 (2007) 75-96
101. Rutgeerts P., Goboes K., Peeters M., Hiele M., Penninckx F., Aerts R., Kerremans R., and Vantrappen G. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 338 (1991) 771-774
102. Rutherford K., Parkhill J., Crook J., Horsnell T., Rice P., Rajandream M.A., and Barrell B. Artemis: sequence visualization and annotation. Bioinformatics 16 (2000) 944-945
103. Sartor R.B. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 3 (2006) 390-407
104. Sartor R.B. Microbial influences in inflammatory bowel diseases. Gastroenterology 134 (2008) 577-594
105. Sasaki M., Sitaraman S.V., Babbin B.A., Gerner-Smidt P., Ribot E.M., Garrett N., Alpern J.A., Akyildiz A., Theiss A.L., Nusrat A., and Klapproth J.M. Invasive Escherichia coli are a feature of Crohn's disease. Lab. Invest. 87 (2007) 1042-1054
106. Satokari R.M., Vaughan E.E., Akkermans A.D., Saarela M., and De Vos W.M. Bifidobacterial diversity in human feces detected by genus-specific PCR and denaturing gradient gel electrophoresis. Appl. Environ. Microbiol. 67 (2001) 504-513
107. Scaldaferri F., and Fiocchi C. Inflammatory bowel disease: progress and current concepts of etiopathogenesis. J. Dig. Dis. 8 (2007) 171-178
108. Scanlan P.D., and Marchesi J.R. Micro-eukaryotic diversity of the human distal gut microbiota: qualitative assessment using culture-dependent and - independent analysis of faeces. ISME J. 2 (2008) 1183-1193
109. Scanlan P.D., Shanahan F., O'Mahony C., and Marchesi J.R. Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease. J. Clin. Microbiol. 44 (2006) 3980-3988
110. Scanlan P.D., Shanahan F., and Marchesi J.R. Human methanogen diversity and incidence in healthy and diseased colonic groups using mcrA gene analysis. BMC Microbiol. 8 (2008) 79
111. Schlee M., Harder J., Koten B., Stange E.F., Wehkamp J., and Fellermann K. Probiotic lactobacilli and VSL#3 induce enterocyte beta-defensin 2. Clin. Exp. Immunol. 151 (2008) 528-535
112. Sepehri S., Kotlowski R., Bernstein C.N., and Krause D.O. Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease. Inflamm. Bowel Dis. 13 (2007) 675-683
113. Seth A., Yan F., Polk D.B., and Rao R.K. Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism. Am. J. Physiol. Gastrointest. Liver Physiol. 294 (2008) G1060-G1069
114. Shale M., and Ghosh S. Beyond TNF, Th1 and Th2 in inflammatory bowel disease. Gut 57 (2008) 1349-1351
115. Soo I., Madsen K.L., Tejpar Q., Sydora B.C., Sherbaniuk R., Cinque B., Di Marzio L., Cifone M.G., Desimone C., and Fedorak R.N. VSL#3 probiotic upregulates intestinal mucosal alkaline sphingomyelinase and reduces inflammation. Can. J. Gastroenterol. 22 (2008) 237-242
116. Standaert-Vitse A., Jouault T., Vandewalle P., Mille C., Seddik M., Sendid B., Mallet J.M., Colombel J.F., and Poulain D. Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn's disease. Gastroenterology 130 (2006) 1764-1775
117. Subramanian S., Roberts C.L., Hart C.A., Martin H.M., Edwards S.W., Rhodes J.M., and Campbell B.J. Replication of colonic Crohn's disease mucosal Escherichia coli isolates within macrophages and their susceptibility to antibiotics. Antimicrob. Agents Chemother. 52 (2008) 427-434
118. Tannock G.W., Munro K., Bibiloni R., Simon M.A., Hargreaves P., Gopal P., Harmsen H., and Welling G. Impact of consumption of oligosaccharide-containing biscuits on the fecal microbiota of humans. Appl. Environ. Microbiol. 70 (2004) 2129-2136
119. Toracchio S., El-Zimaity H.M., Urmacher C., Katz S., and Graham D.Y. Mycobacterium avium subspecies paratuberculosis and Crohn's disease granulomas. Scand. J. Gastroenterol. 43 (2008) 1108-1111
120. Torii A., Torii S., Fujiwara S., Tanaka H., Inagaki N., and Nagai H. Lactobacillus acidophilus strain L-92 regulates the production of Th1 cytokine as well as Th2 cytokines. Allergol. Int. 56 (2007) 293-301
121. Tsuji M., Suzuki K., Kinoshita K., and Fagarasan S. Dynamic interactions between bacteria and immune cells leading to intestinal IgA synthesis. Semin. Immunol. 20 (2008) 59-66
122. Turnbaugh P.J., Backhed F., Fulton L., and Gordon J.I. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3 (2008) 213-223
123. Turnbaugh P.J., Hamady M., Yatsunenko T., Cantarel B.L., Duncan A., Ley R.E., Sogin M.L., Jones W.J., Roe B.A., Affourtit J.P., Egholm M., Henrissat B., Heath A.C., Knight R., and Gordon J.I. A core gut microbiome in obese and lean twins. Nature 457 (2009) 480-484
124. Ukena S.N., Singh A., Dringenberg U., Engelhardt R., Seidler U., Hansen W., Bleich A., Bruder D., Franzke A., Rogler G., Suerbaum S., Buer J., Gunzer F., and Westendorf A.M. Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. PLoS One 2 (2007) e1308
125. Underhill D., and Braun J. Current understanding of fungal microflora in inflammatory bowel disease pathogenesis. Inflamm. Bowel Dis. 14 (2008) 1147-1153
126. Van Gossum A., Dewit O., Louis E., de H.G., Baert F., Fontaine F., DeVos M., Enslen M., Paintin M., and Franchimont D. Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after lleo-caecal resection. Inflamm. Bowel Dis. 13 (2007) 135-142
127. Vasquez N., Mangin I., Lepage P., Seksik P., Duong J.P., Blum S., Schiffrin E., Suau A., Allez M., Vernier G., Treton X., Dore J., Marteau P., and Pochart P. Patchy distribution of mucosal lesions in ileal Crohn's disease is not linked to differences in the dominant mucosa-associated bacteria: a study using fluorescence in situ hybridization and temporal temperature gradient gel electrophoresis. Inflamm. Bowel Dis. 13 (2007) 684-692
128. Walter J., Hertel C., Tannock G.W., Lis C.M., Munro K., and Hammes W.P. Detection of Lactobacillus, Pediococcus, Leuconostoc, and Weissella species in human feces by using group-specific PCR primers and denaturing gradient gel electrophoresis. Appl. Environ. Microbiol. 67 (2001) 2578-2585
129. Yuvaraj S., Peppelenbosch M.P., and Bos N.A. Transgenic probiotica as drug delivery systems: the golden bullet? Expert Opin. Drug Deliv. 4 (2007) 1-3
130. Zeng J., Li Y.Q., Zuo X.L., Zhen Y.B., Yang J., and Liu C.H. Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome. Aliment. Pharmacol. Ther. 28 (2008) 994-1002
131. Zhang H., Massey D., Tremelling M., and Parkes M. Genetics of inflammatory bowel disease: clues to pathogenesis. Br. Med. Bull. 87 (2008) 17-30
132. Zocco M.A., dal Verme L.Z., Cremonini F., Piscaglia A.C., Nista E.C., Candelli M., Novi M., Rigante D., Cazzato I.A., Ojetti V., Armuzzi A., Gasbarrini G., and Gasbarrini A. Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis. Aliment. Pharmacol. Ther. 23 (2006) 1567-1574
133. Zoumpopoulou G., Tsakalidou E., Dewulf J., Pot B., and Grangette C. Differential crosstalk between epithelial cells, dendritic cells and bacteria in a co-culture model. Int. J. Food Microbiol. 131 (2009) 40-51
134. Zyrek A.A., Cichon C., Helms S., Enders C., Sonnenborn U., and Schmidt M.A. Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair. Cell. Microbiol. 9 (2007) 804-816